Nantahala Capital Management’s Acer Therapeutics Inc. Common Stock (DE) ACER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-918,349
| Closed | -$748K | – | 132 |
|
|
2023
Q3 | $748K | Sell |
918,349
-218,067
| -19% | -$178K | 0.06% | 91 |
|
|
2023
Q2 | $1.05M | Sell |
1,136,416
-66,710
| -6% | -$61.6K | 0.1% | 77 |
|
|
2023
Q1 | $913K | Sell |
1,203,126
-23,065
| -2% | -$17.5K | 0.07% | 84 |
|
|
2022
Q4 | $3.08M | Buy |
1,226,191
+529,653
| +76% | +$1.33M | 0.2% | 56 |
|
|
2022
Q3 | $968K | Sell |
696,538
-44,472
| -6% | -$61.8K | 0.06% | 76 |
|
|
2022
Q2 | $934K | Sell |
741,010
-36,810
| -5% | -$46.4K | 0.05% | 79 |
|
|
2022
Q1 | $2.26M | Sell |
777,820
-123,470
| -14% | -$358K | 0.1% | 69 |
|
|
2021
Q4 | $2.06M | Sell |
901,290
-12,907
| -1% | -$29.4K | 0.07% | 82 |
|
|
2021
Q3 | $2.34M | Sell |
914,197
-20,558
| -2% | -$52.6K | 0.07% | 79 |
|
|
2021
Q2 | $2.67M | Hold |
934,755
| – | – | 0.08% | 83 |
|
|
2021
Q1 | $2.91M | Sell |
934,755
-55,000
| -6% | -$171K | 0.09% | 76 |
|
|
2020
Q4 | $2.59M | Sell |
989,755
-900
| -0.1% | -$2.36K | 0.08% | 86 |
|
|
2020
Q3 | $2.85M | Hold |
990,655
| – | – | 0.09% | 80 |
|
|
2020
Q2 | $3.4M | Hold |
990,655
| – | – | 0.1% | 75 |
|
|
2020
Q1 | $1.97M | Hold |
990,655
| – | – | 0.07% | 75 |
|
|
2019
Q4 | $3.97M | Hold |
990,655
| – | – | 0.12% | 56 |
|
|
2019
Q3 | $3.16M | Hold |
990,655
| – | – | 0.12% | 65 |
|
|
2019
Q2 | $3.86M | Buy |
990,655
+106,200
| +12% | +$414K | 0.12% | 63 |
|
|
2019
Q1 | $21.5M | Sell |
884,455
-19,000
| -2% | -$462K | 0.67% | 23 |
|
|
2018
Q4 | $18.2M | Buy |
903,455
+212,067
| +31% | +$4.27M | 0.56% | 28 |
|
|
2018
Q3 | $21.3M | Buy |
691,388
+441,136
| +176% | +$13.6M | 0.57% | 26 |
|
|
2018
Q2 | $5.41M | Hold |
250,252
| – | – | 0.22% | 43 |
|
|
2018
Q1 | $4.82M | Buy |
+250,252
| New | +$4.82M | 0.22% | 43 |
|